Seminars in nuclear medicine, 40(2), 105-121 (2010-02-02)
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. There is growing evidence for efficiency in liver tumors of various entities, with the most prominent ones
Journal of nanoscience and nanotechnology, 14(6), 4207-4213 (2014-04-18)
YF3:Er3+ hollow nanofibers were successfully fabricated via fluorination of the relevant Y2O3:Er3+ hollow nanofibers which were obtained by calcining the electrospun PVP/[Y(NO3)3 + Er(NO3)3] composite nanofibers. The morphology and properties of the products were investigated in detail by X-ray diffraction
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 31(8), 781-785 (2015-08-11)
With a view to enhance the sensitivity of analytical instruments used in the measurement of trace elements contained in a single cell, we have now equipped the previously reported micro-droplet injection system (M-DIS) with a desolvation system. This modified M-DIS
Dalton transactions (Cambridge, England : 2003), 44(30), 13522-13529 (2015-07-03)
Nanoscopic yttrium acetate fluorides Y(CH(3)COO)(3-z)F(z) and yttrium oxide fluorides YO(3-z)/(2)F(z )were prepared with tunable Y/F molar ratios via the fluorolytic sol-gel route. All samples were characterized by X-ray diffraction, elemental analysis and thermal analysis. In addition, local structures of all
Molecular cancer therapeutics, 13(12), 2978-2990 (2014-10-15)
Tivantinib (ARQ197) was first reported as a highly selective inhibitor of c-MET and is currently being investigated in a phase III clinical trial. However, as recently reported by us and another group, tivantinib showed cytotoxic activity independent of cellular c-MET
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
